164 related articles for article (PubMed ID: 1976143)
1. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.
Coles C; Thompson AM; Elder PA; Cohen BB; Mackenzie IM; Cranston G; Chetty U; Mackay J; Macdonald M; Nakamura Y
Lancet; 1990 Sep; 336(8718):761-3. PubMed ID: 1976143
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
Thorlacius S; Jonasdottir O; Eyfjord JE
Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
[TBL] [Abstract][Full Text] [Related]
4. Allele loss on short arm of chromosome 17 in breast cancers.
Mackay J; Steel CM; Elder PA; Forrest AP; Evans HJ
Lancet; 1988 Dec; 2(8625):1384-5. PubMed ID: 2904522
[TBL] [Abstract][Full Text] [Related]
5. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
6. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
[TBL] [Abstract][Full Text] [Related]
9. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
[TBL] [Abstract][Full Text] [Related]
10. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
Thompson AM; Steel CM; Chetty U; Hawkins RA; Miller WR; Carter DC; Forrest AP; Evans HJ
Br J Cancer; 1990 Jan; 61(1):74-8. PubMed ID: 2137009
[TBL] [Abstract][Full Text] [Related]
12. Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.
Lindblom A; Skoog L; Andersen TI; Rotstein S; Nordenskjöld M; Larsson C
Hum Genet; 1993 Mar; 91(1):6-12. PubMed ID: 8454289
[TBL] [Abstract][Full Text] [Related]
13. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.
Devilee P; van den Broek M; Kuipers-Dijkshoorn N; Kolluri R; Khan PM; Pearson PL; Cornelisse CJ
Genomics; 1989 Oct; 5(3):554-60. PubMed ID: 2575586
[TBL] [Abstract][Full Text] [Related]
14. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
Park SY; Kang YS; Kim BG; Lee SH; Lee ED; Lee KH; Park KB; Lee JH
Cancer Genet Cytogenet; 1995 Jan; 79(1):74-8. PubMed ID: 7850756
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.
Devilee P; Cornelisse CJ; Kuipers-Dijkshoorn N; Jonker C; Pearson PL
Cytogenet Cell Genet; 1990; 53(1):52-4. PubMed ID: 1969789
[TBL] [Abstract][Full Text] [Related]
17. Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions.
Cornelis RS; Devilee P; van Vliet M; Kuipers-Dijkshoorn N; Kersenmaeker A; Bardoel A; Khan PM; Cornelisse CJ
Oncogene; 1993 Mar; 8(3):781-5. PubMed ID: 8437862
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
19. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas.
Wu JK; Darras BT
Neurol Res; 1992 Mar; 14(1):39-44. PubMed ID: 1351257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
